Introducing Acutis Reveal™ respiratory, gastrointestinal and pharyngeal tests
The science and technology of molecular detection of infectious diseases offer greater certainty while expediting the diagnostic process.
From its inception, Acutis has been driven by a straightforward and rigorous philosophy: identify a problem, test and determine the most appropriate solution, and then work to refine that solution.
In practice, this has meant acquiring and continually refining
state-of-the-art resources while working to raise industry standards.
By adhering to this discipline, we became a leader in clinical toxicology. Today, building on this practice, we have added a new competence: molecular detection of infectious diseases.
increasing numbers of infectious diseases, exposing more people to serious illness
Acutis Reveal™ provides more accurate test results, delivered in a more timely manner
Physicians, pediatricians and healthcare workers have never been so hard pressed. The demand for their services, the costs related to their work, compounded by the expectations of their patients, can be overwhelming.
In both respiratory and gastrointestinal illnesses, symptoms are too often too similar to distinguish the infectious from the non-infectious. No one sign points convincingly to a particular viral, bacterial or parasitic cause. This ambiguity has created a new sense of urgency, one traditional tests, lacking both rigor and precision, fail to ameliorate.
Acutis Reveal™ addresses and resolves problem by identifying specific pathogens, with significantly more accurate positive and negative predictive results. These strong data enable healthcare professionals to optimize their performance by providing significantly more accurate test results with a measurably faster turnaround.
actionable data, whether testing for respiratory or gastrointestinal infections
Our tests quickly identify pathogens, determine what is present, and, most importantly,
answer questions as to whether the infection is viral, bacterial or parasitic in nature.
What’s more, we can return test results in as few as 5 to 24 hours
from the time a sample arrives at our lab.
Acutis Reveal™ enables medical providers to devise the most personal course of treatment and do it with a greater degree of certainty. More confident diagnoses place less stress on a practice while relieving patients, particularly parents of children, of the anxiety related to infectious diseases.
Discover the 3 new Acutis Reveal™ tests in details
Acutis Reveal™ respiratory tests
Acutis Reveal™ gastrointestinal test
Acutis Reveal™ pharyngeal test
Benefits at a glance:
Exacting science that identifies the nature of a pathogen,
removing ambiguity presented by similar symptoms
Extreme sensitivity for more precise identification of pathogens
Rapid results delivered quickly, as early as 5 to 24 hours from receipt of sample
The confidence of knowing with near certainty the cause and seriousness of an illness, and the satisfaction of relieving your patients’ fears and anxieties.
Click, act & go
Sign in to view your patients' results and order new tests.
Make a payment
I am paying on behalf of a patient or a practice.
Arrange a sample pick-up
Our internal systems ensure accurate
and timely pick-up of samples.
Our logistics specialists see that materials are
shipped exactly where and when you need them.
Our areas of expertise
Acutis Reveal™: molecular tests for infectious diseases
Tests and systems that detect prescription drug abuse and misuse.
& addiction detection
Innovative practices and procedures that quickly deliver critical information.
News & insights
Come meet Acutis at Pri-Med Washington, DC.
Acutis Diagnostics will be in attendance on both April 17th & 18th. The importance of this event was made clear by a number of our clients in pain management and infectious diseases. On the basis of their recommendations, our representatives, Tiffany DiPietro, Nicole Summers, and Stephanie Moorefield, will be on hand to meet with attendees and introduce them to our company.
Tiffany DiPietro, Nicole Summers, and Stephanie Moorefield